In cervical cancer [14], breast cancer [15,16], bladder cancer [17], HCC [18], lung cancer [23], prostate cancer [24] and other malignancies, SPAG5 is highly expressed in tumor tissues, indicating a poor prognosis. Here, SPAG5 is linked to urinary bladder cancer.